Shareholders

Arrow Down Icon

Rigvir inventor Aina Muceniece family - 87%



Venture fund Pharma VC - 5%



Guizhou Sinorda Biomedicine Co. Ltd. - 1.5% (Latima Ltd.)



Private investors - 8%

Private company

In the industry since 2002 with a focus on oncolytic virotherapy

Rigvir Group: established in 2014

2018: implementation of the restructuring strategy to become a sustainable Biotechnological Company